AN2's stock craters as phase 3 lung disease trial for lead antibiotic paused over efficacy

0

12.02.2024 15:42

Fiercebiotech.com

AN2's stock craters as phase 3 lung disease trial for lead antibiotic paused over efficacy jwaldron Mon, 02/12/2024 - 07:42

СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *